Main Content

Reportable Cancer List DX 10/2015 or later

REPORTABLE CASES – MISSISSIPPI

For cases diagnosed 10/1/2015 and after

The following lists are intended to assist you, as the reporter, in identifying the reportable neoplasms for your facility. Any reportable neoplasms diagnosed on or after January 1, 1996 should be reported to the Mississippi Cancer Registry.

REPORTABLE NEOPLASMS

• Malignant neoplasms (exclusions noted below)
• Benign and borderline neoplasms of the central nervous system (Cases diagnosed on or after January 1, 2004)
• Pilocytic/juvenile astrocytoma listed as 9421/1 in ICD-O-3, is reportable, and should be coded to 9421/3.
• Squamous intraepithelial neoplasia grade III of vulva [VIN], vagina [VAIN], and anus [AIN] beginning with 2001 cases.
• Carcinoid, NOS of the appendix is reportable and should be coded 8240/3 (Cases diagnosed on or after January 1, 2015)
• Gastrointestinal Stromal Tumor (GIST), NOS with multiple tumor foci and/or metastasis to lymph nodes or distant sites.
• Thymoma, NOS with multiple tumor foci and/or metastasis to lymph nodes or distant sites.
• Malignant GIST and malignant thymomas

NON-REPORTABLE NEOPLASMS

• Basal and squamous cell carcinomas of the skin (ICD-O-3 Histologies 8090-8110)
• Epithelial carcinomas of the skin (ICD-O-3 Histologies 8010-8046)
• Papillary and squamous cell carcinomas of the skin (ICD-O-3 Histologies 8050-8084)
• Malignant neoplasms, NOS of the skin (ICD-O-3 Histologies 8000-8005)
• Carcinoma in-situ of the cervix
• Intraepithelial neoplasms of the cervix (ICD-O-3 Histology 8077/2) or prostate (ICD-O-3 Histology 8148/2)
• Borderline cystadenomas (ICD-O-3 Histologies 8442, 8451, 8462, 8472, 8473), of the ovaries with behavior code "1" are not collected as of January 1, 2001
• Cyst, brain or CNS tumor that does not have an ICD-O-3 code as of January 1, 2004
• Gastrointestinal Stromal Tumor (GIST), NOS that are not stated to be malignant and are a single tumor with no metastasis to nodes or distant sites
• Thymoma, NOS that are not stated to be malignant and are a single tumor with no metastasis to nodes or distant sites
• Severe dysplasia of any site including the Gastrointestinal There must be a statement that this is carcinoma in situ to be reportable.

AMBIGUOUS TERMINOLOGY

Exceptions:

• If a cytology is reported using any ambiguous term, do not interpret it as a diagnosis of cancer. Abstract the case only if a positive biopsy or a physician’s clinical impression of cancer supports the cytology findings.
• Genetic findings in the absence of pathologic or clinical evidence of reportable disease are indicative of risk only and do not constitute a diagnosis.

There are other ambiguous terms used by physicians that are related to staging. Some may indicate tumor involvement or extension, while others are not considered to be involvement. Refer to Collaborative Staging Manual and Coding Instructions for a listing of those terms.

COMPREHENSIVE ICD-10-CM CASEFINDING CODE LIST FOR REPORTABLE TUMORS

¹ Note: Pilocytic/juvenile astrocytoma M-9421 moved from behavior /3 (malignant) to /1 (borderline malignancy) in ICD-O-3. However, these cases should be reported and behavior coded as /3 (malignant).

SUPPLEMENTAL CASEFINDING LIST TO BE SCREENED FOR REPORTABLE CONDITIONS

Cases with the following codes should be screened as time allows. Experience has shown that use of this supplemental list increases casefinding for benign brain and CNS, hematopoietic neoplasms and other reportable diseases.